Remote Irritable Bowel Syndrome (IBS) Monitoring Industry Analysis Report, 2025-2029 & 2034 - Digital Innovations Drive IBS Monitoring Growth Amid Rising Gastrointestinal Disorders - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Remote Irritable Bowel Syndrome (IBS) Monitoring Global Market Report 2025" has been added to ResearchAndMarkets.com's offering.

The remote irritable bowel syndrome (IBS) monitoring market is experiencing significant growth, with projections indicating an increase from $1.21 billion in 2024 to $1.4 billion by 2025, at a CAGR of 16.2%. This expansion is driven by the rising prevalence of gastrointestinal disorders, heightened awareness of digestive health, increasing demand for non-invasive solutions, and widespread adoption of digital health technologies. The escalation of smartphone and wearable device usage, coupled with increased healthcare spending and a stronger focus on patient-centered care, further bolster this growth trajectory.

Looking ahead, the market is expected to reach $2.53 billion by 2029, propelled by a CAGR of 15.8%. Key factors contributing to this forecast include the integration of connected devices for gastrointestinal monitoring, heightened adoption of telehealth, demand for personalized treatments, and expansion of remote monitoring programs. Technological advancements, such as biosensors, AI-based symptom tracking, and cloud-based health platforms, are expected to play pivotal roles, alongside innovations in gut microbiome analysis and digital therapeutics.

The increase in gastrointestinal disorders remains a key driver of market growth. With reports citing a substantial rise in cases, remote IBS monitoring is positioned as a crucial tool in improving patient outcomes by reducing symptom severity through early detection and management. For instance, Crohn's & Colitis Australia projects a surge in inflammatory bowel disease cases from 20,511,881 in 2023 to 23,067,771 by 2030, highlighting a rising demand for effective monitoring solutions.

Leading market players are focusing on innovative service models to enhance accessibility and operational efficacy. Salvo Health unveiled its first remote patient monitoring solution for chronic gastrointestinal conditions, blending digital care with traditional in-person services. Similarly, Mahana Therapeutics expanded its global reach by acquiring HiDoc Technologies, further strengthening its digestive health portfolio through digital therapies.

Key industry players include Indegene, Vivante Health, Thryve Health, Heali AI Corp., Mahana Therapeutics Inc., metaMe Health Inc., among others. Market research highlights North America as the leading region in 2024, with Asia-Pacific anticipated to experience the fastest growth during the forecast period.

However, the market faces challenges from global trade relations and tariffs, particularly affecting the healthcare sector's supply chains. The healthcare industry is adapting by exploring local manufacturing and advocating tariff exemptions to mitigate these disruptions.

Report Scope

The comprehensive report on the remote IBS monitoring market delves into the industry's size, trends, opportunities, and challenges, providing an exhaustive analysis of current and future scenarios. This report offers crucial insights for stakeholders aiming to leverage market potential in the rapidly evolving digital health landscape.

Markets Covered:

• By Component: Devices, Software, Services
• By Application: Diagnosis, Symptom Tracking, Treatment Management, Patient Education, Other Applications
• By End-User: Hospitals and Clinics, Homecare Settings, Research Institutes, Other End-Users

Subsegments:

• By Devices: Wearable, Non-Wearable, Portable, Implantable
• By Software: Data Analytics, Mobile Health Apps, Remote Monitoring Platforms, Cloud Solutions
• By Services: Teleconsultation, Data Management, Technical Support, Training

Countries and Regions:

• Countries: Australia, Brazil, China, France, Germany, India, Japan, UK, USA, and more
• Regions: Asia-Pacific, Western Europe, North America, and others

Companies Mentioned: Indegene, Vivante Health, Thryve Health, Heali AI Corp., Mahana Therapeutics Inc., and others including leading health tech firms.

The report is available for delivery in PDF, Word, and an Excel Data Dashboard format, offering versatility for detailed data extraction and analysis.

Key Attributes:

Report Attribute	Details
No. of Pages	250
Forecast Period	2025 - 2029
Estimated Market Value (USD) in 2025	$1.4 Billion
Forecasted Market Value (USD) by 2029	$2.53 Billion
Compound Annual Growth Rate	15.8%
Regions Covered	Global

The companies featured in this Remote Irritable Bowel Syndrome (IBS) Monitoring market report include:

• Indegene
• Vivante Health
• Thryve Health
• Heali AI Corp.
• Mahana Therapeutics Inc.
• metaMe Health Inc.
• Seed Health
• Ayble Health
• Oshi health
• Salvo Health Inc.
• modifyhealth Inc.
• Food Marble
• nerva Health
• MyGiHealth
• Sun Genomics
• Dietahealth
• Dige Health
• Nori Health
• Sequenex
• Bowelle

For more information about this report visit https://www.researchandmarkets.com/r/c8puk5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.